BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18841955)

  • 1. Potential nicotinic acetylcholine receptor ligands from 2,4-methanoproline derivatives.
    Patel AB; Malpass JR
    J Med Chem; 2008 Nov; 51(21):7005-9. PubMed ID: 18841955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel acetylcholine and carbamoylcholine analogues: development of a functionally selective alpha4beta2 nicotinic acetylcholine receptor agonist.
    Hansen CP; Jensen AA; Christensen JK; Balle T; Liljefors T; Frølund B
    J Med Chem; 2008 Dec; 51(23):7380-95. PubMed ID: 18989912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of 1-substituents in the 2-azabicyclo[2.1.1]hexane ring system; approaches to potential nicotinic acetylcholine receptor ligands from 2,4-methanoproline derivatives.
    Malpass JR; Patel AB; Davies JW; Fulford SY
    J Org Chem; 2003 Nov; 68(24):9348-55. PubMed ID: 14629156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them.
    Xiao Y; Fan H; Musachio JL; Wei ZL; Chellappan SK; Kozikowski AP; Kellar KJ
    Mol Pharmacol; 2006 Oct; 70(4):1454-60. PubMed ID: 16857741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulators of nicotinic acetylcholine receptors as analgesics.
    Jain KK
    Curr Opin Investig Drugs; 2004 Jan; 5(1):76-81. PubMed ID: 14983978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octahydropyrrolo[3,4-c]pyrrole: a diamine scaffold for construction of either alpha4beta2 or alpha7-selective nicotinic acetylcholine receptor (nAChR) ligands. Substitutions that switch subtype selectivity.
    Bunnelle WH; Tietje KR; Frost JM; Peters D; Ji J; Li T; Scanio MJ; Shi L; Anderson DJ; Dyhring T; Grønlien JH; Ween H; Thorin-Hagene K; Meyer MD
    J Med Chem; 2009 Jul; 52(14):4126-41. PubMed ID: 19552432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational evidence for the ligand selectivity to the alpha4beta2 and alpha3beta4 nicotinic acetylcholine receptors.
    Yuan H; Petukhov PA
    Bioorg Med Chem; 2006 Dec; 14(23):7936-42. PubMed ID: 16919961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity studies and analgesic efficacy of N-(3-pyridinyl)-bridged bicyclic diamines, exceptionally potent agonists at nicotinic acetylcholine receptors.
    Bunnelle WH; Daanen JF; Ryther KB; Schrimpf MR; Dart MJ; Gelain A; Meyer MD; Frost JM; Anderson DJ; Buckley M; Curzon P; Cao YJ; Puttfarcken P; Searle X; Ji J; Putman CB; Surowy C; Toma L; Barlocco D
    J Med Chem; 2007 Jul; 50(15):3627-44. PubMed ID: 17585748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7-Azaindole derivatives as potential partial nicotinic agonists.
    Stoit AR; den Hartog AP; Mons H; van Schaik S; Barkhuijsen N; Stroomer C; Coolen HK; Reinders JH; Adolfs TJ; van der Neut M; Keizer H; Kruse CG
    Bioorg Med Chem Lett; 2008 Jan; 18(1):188-93. PubMed ID: 18006307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On-line screening of conformationally constrained nicotines and anabasines for agonist activity at the alpha3beta4- and alpha4beta2-nicotinic acetylcholine receptors using immobilized receptor-based liquid chromatographic stationary phases.
    Moaddel R; Jozwiak K; Yamaguchi R; Cobello C; Whittington K; Sarkar TK; Basak S; Wainer IW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):235-40. PubMed ID: 15556538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and affinity profile of novel nicotinic ligands.
    Charton Y; Guillonneau C; Lockhart B; Lestage P; Goldstein S
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2188-93. PubMed ID: 18262785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of N-substituted ligands for the alpha7 nicotinic acetylcholine receptor.
    Mortell KH; Schrimpf MR; Bunnelle WH; Anderson DJ; Gronlien JH; Hagene KT; Gopalakrishnan M
    Bioorg Med Chem Lett; 2010 Jan; 20(1):104-7. PubMed ID: 19954975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165.
    Sharples CG; Karig G; Simpson GL; Spencer JA; Wright E; Millar NS; Wonnacott S; Gallagher T
    J Med Chem; 2002 Jul; 45(15):3235-45. PubMed ID: 12109907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes.
    Tasso B; Canu Boido C; Terranova E; Gotti C; Riganti L; Clementi F; Artali R; Bombieri G; Meneghetti F; Sparatore F
    J Med Chem; 2009 Jul; 52(14):4345-57. PubMed ID: 19548687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New analogues of epiboxidine incorporating the 4,5-dihydroisoxazole nucleus: synthesis, binding affinity at neuronal nicotinic acetylcholine receptors, and molecular modeling investigations.
    Dallanoce C; Magrone P; Bazza P; Grazioso G; Rizzi L; Riganti L; Gotti C; Clementi F; Frydenvang K; De Amici M
    Chem Biodivers; 2009 Feb; 6(2):244-59. PubMed ID: 19235154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary three-dimensional quantitative structure-activity relationship modeling of binding affinity and functional potency: a study on alpha4beta2 nicotinic ligands.
    Tosco P; Ahring PK; Dyhring T; Peters D; Harpsøe K; Liljefors T; Balle T
    J Med Chem; 2009 Apr; 52(8):2311-6. PubMed ID: 19301898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into docking and scoring neuronal alpha4beta2 nicotinic receptor agonists using molecular dynamics simulations and QM/MM calculations.
    Sgrignani J; Bonaccini C; Grazioso G; Chioccioli M; Cavalli A; Gratteri P
    J Comput Chem; 2009 Nov; 30(15):2443-54. PubMed ID: 19360794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel alpha4beta2 nicotinic acetylcholine receptor selective agonists.
    Ji J; Schrimpf MR; Sippy KB; Bunnelle WH; Li T; Anderson DJ; Faltynek C; Surowy CS; Dyhring T; Ahring PK; Meyer MD
    J Med Chem; 2007 Nov; 50(22):5493-508. PubMed ID: 17929796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel series of [3.2.1] azabicyclic biaryl ethers as alpha3beta4 and alpha6/4beta4 nicotinic receptor agonists.
    Lowe JA; DeNinno SL; Coe JW; Zhang L; Mente S; Hurst RS; Mather RJ; Ward KM; Shrikhande A; Rollema H; Johnson DE; Horner W; Gorczyca R; Tingley FD; Kozak R; Majchrzak MJ; Tritto T; Sadlier J; Shaffer CL; Ellerbrock B; Osgood SM; MacDougall MC; McDowell LL
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4749-52. PubMed ID: 20663668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chain length dependence of the interactions of bisquaternary ligands with the Torpedo nicotinic acetylcholine receptor.
    Carter CR; Cao L; Kawai H; Smith PA; Dryden WF; Raftery MA; Dunn SM
    Biochem Pharmacol; 2007 Feb; 73(3):417-26. PubMed ID: 17118342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.